Systematic Reviews
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2280-2293
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2280
Table 2 Tumour characteristics and computed tomography modality used
Ref.
Primary tumour location
Tumour histology
CT modality
Burbidge et al[28], 2013-Adenocarcinoma (220, 100%)Multidetector CT with gastric staging protocol
Li et al[29], 2020--Unenhanced, two-phase dynamic enhanced CT
Davies et al[30], 1997-Adenocarcinoma (105, 100%)Philips Tomoscan SR 7000 scanner (120 Kvp and 225-300 mAs), contrast enhanced spiral CT
Kim et al[31], 2009-Intestinal (162, 32.5%) 16-detector row (n = 427) or 64-detector row (n = 71) scanners
Diffuse (336, 67.5%)
Stell et al[32], 1996Proximal third (60, 58.3%)Adenocarcinoma (103, 100%)Contrast-enhanced CT using a GE model 9800 Hilight whole-body scanner (GEC, Milwaukee, Wisconsin, United States)
Body (24, 23.3%)
Antrum (10, 9.7%)
Body and antrum (6, 5.8%)
Fundus (2, 1.9%)
Linitis plastica (1, 1%)
Asencio et al[58], 1997Upper third (12, 17%)Adenocarcinoma (71, 100%)Dynamic contrast-enhanced CT
Middle third (21, 30%)
Lower third (19, 27%)
Fujimura et al[59], 2002Japanese classification of gastric carcinoma type 1 (1, 2.6%); type 2 (4, 10.3%); type 3 (14, 35.9%); type 4 (20, 51.3%)Differentiated (16, 41%)CT
Undifferentiated (23, 59%)
Leeman et al[60], 2017Proximal (7, 9.5%)Adenocarcinoma (74, 100%)Toshiba Aquilion 16 (16 slice), Siemens Somatom Sensation 16 (16 slice), Toshiba Aquilion Multi (4 slice)
Body (23, 31.1%)
Distal (10, 13.5%)
Linitis plastica (6, 8.1%)